CNBX Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Year Ending	Current	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	2018 - 2013
Market Capitalization	0	0	4	25	26	35	Upgrade
Market Cap Growth	172.38%	-91.76%	-82.85%	-3.36%	-26.45%	-68.25%	Upgrade
Enterprise Value	2	2	6	24	24	31	Upgrade
Last Close Price	0.01	0.02	3.40	20.40	22.92	31.30	Upgrade
PE Ratio	-	-0.04	-1.12	-7.37	-3.44	30.49	Upgrade
PS Ratio	0.58	0.86	142.76	-	3604.91	3563.68	Upgrade
PB Ratio	-0.11	-0.17	-2.62	13.81	14.62	2.38	Upgrade
P/FCF Ratio	-1.58	-3.13	-2.54	-10.00	-9.05	-10.60	Upgrade
P/OCF Ratio	-1.60	-3.13	-2.55	-10.00	-9.30	-11.34	Upgrade
EV/Sales Ratio	2.83	4.00	193.13	-	3404.51	3121.90	Upgrade
EV/EBITDA Ratio	-2.64	-2.13	-2.10	-10.09	-8.62	-9.87	Upgrade
EV/EBIT Ratio	-2.22	-1.76	-1.96	-9.24	-8.01	-9.30	Upgrade
EV/FCF Ratio	-8.69	-14.58	-3.44	-9.63	-8.55	-9.28	Upgrade
Debt / Equity Ratio	-0.53	-0.67	-1.08	0.48	-	-	Upgrade
Debt / FCF Ratio	-7.32	-11.94	-1.05	-0.35	-	-	Upgrade
Asset Turnover	0.62	0.63	0.02	-	0.00	0.00	Upgrade
Quick Ratio	0.03	0.05	0.05	1.09	1.71	9.17	Upgrade
Current Ratio	0.03	0.09	0.08	1.25	2.04	9.81	Upgrade
Return on Equity (ROE)	-	-	-4289.36%	-178.94%	-90.47%	13.03%	Upgrade
Return on Assets (ROA)	-116.59%	-88.86%	-94.92%	-61.34%	-21.86%	-22.48%	Upgrade
Return on Capital (ROIC)	-	-	-131.68%	-73.16%	-23.04%	-23.75%	Upgrade
Earnings Yield	-388.34%	-1052.38%	-87.05%	-12.81%	-28.94%	3.23%	Upgrade
FCF Yield	-56.80%	-31.92%	-39.30%	-10.00%	-11.05%	-9.44%	Upgrade
Buyback Yield / Dilution	-235.76%	-621.77%	-5.92%	-2.95%	-1.59%	-10.03%	Upgrade
Total Shareholder Return	-235.76%	-621.77%	-5.92%	-2.95%	-1.59%	-10.03%	Upgrade

Source: S&P Capital IQ. Standard template.